- Home
- ARTL vs IVP Comparison
ARTL vs IVP Comparison
Compare ARTL & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTL
- IVP
- Stock Information
- Founded
- ARTL 2011
- IVP 2020
- Country
- ARTL United States
- IVP United States
- Employees
- ARTL N/A
- IVP N/A
- Industry
- ARTL Biotechnology: Pharmaceutical Preparations
- IVP Diversified Commercial Services
- Sector
- ARTL Health Care
- IVP Miscellaneous
- Exchange
- ARTL Nasdaq
- IVP Nasdaq
- Market Cap
- ARTL 3.6M
- IVP 3.0M
- IPO Year
- ARTL N/A
- IVP 2023
- Fundamental
- Price
- ARTL $0.95
- IVP $1.28
- Analyst Decision
- ARTL Strong Buy
- IVP
- Analyst Count
- ARTL 2
- IVP 0
- Target Price
- ARTL $5.50
- IVP N/A
- AVG Volume (30 Days)
- ARTL 1.2M
- IVP 46.2K
- Earning Date
- ARTL 05-12-2025
- IVP 05-14-2025
- Dividend Yield
- ARTL N/A
- IVP N/A
- EPS Growth
- ARTL N/A
- IVP N/A
- EPS
- ARTL N/A
- IVP N/A
- Revenue
- ARTL N/A
- IVP $16,592,109.00
- Revenue This Year
- ARTL N/A
- IVP N/A
- Revenue Next Year
- ARTL N/A
- IVP N/A
- P/E Ratio
- ARTL N/A
- IVP N/A
- Revenue Growth
- ARTL N/A
- IVP N/A
- 52 Week Low
- ARTL $0.82
- IVP $1.28
- 52 Week High
- ARTL $1.59
- IVP $401.50
- Technical
- Relative Strength Index (RSI)
- ARTL 50.27
- IVP 25.02
- Support Level
- ARTL $0.82
- IVP $1.39
- Resistance Level
- ARTL $1.40
- IVP $1.50
- Average True Range (ATR)
- ARTL 0.11
- IVP 0.12
- MACD
- ARTL 0.02
- IVP -0.01
- Stochastic Oscillator
- ARTL 23.10
- IVP 3.85
About ARTL Artelo Biosciences Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.